Feature | May 19, 2011| Mike Rodman, Cath Lab Supervisor, Appleton Medical Center, Appleton, Wis., and Theda Clark Medical Center, Neenah, Wis.

Door-to-Balloon Times: 60 Minutes or Less

Lean management helps improve patient care in the cath lab by increasing efficiency

Pre-hospital ECG transmissions helped ThedaCare diagnose STEMI patients prior to arrival, allowing earlier cath lab activation.

The Philips InnerCool system uses both surface and endovascular cooling. Hypothermia may help reduce infarct volume in STEMI.

According to the American College of Cardiology (ACC), each year nearly 400,000 patients are admitted to U.S. hospitals with ST segment elevation myocardial infarction (STEMI). National ACC/American Heart Association (AHA) guidelines state that hospitals treating STEMI patients with emergency percutaneous coronary interventions (PCI) should reliably achieve a door-to-balloon time (D2B) of 90 minutes or less, and studies have demonstrated strong associations between time to primary PCI and in-hospital mortality risk.

However, reducing and sustaining D2B times can be challenging. To achieve this goal, ThedaCare, a community health system consisting of four hospitals in northeast Wisconsin, underwent a complete cultural transformation to improve processes in the cath lab.

Transforming a Culture: Going Lean to Improve STEMI Times

For the past seven years, ThedaCare has been working with a lean management consulting firm, Simpler Consulting, to coach hospital staff on the application of lean management skills to relieve overburdened employees, improve patient care and save dollars on the bottom line by applying a hospital-wide strategy that seeks improvement across the network. Since the lean implementation, ThedaCare has experienced a total bottom-line savings of more than $27 million and has found success in countless departments of the hospital, including the cath labs at Appleton Medical Center and Theda Clark Medical Center.

When ThedaCare began its lean transformation in the cath labs in 2004, the national standard for D2B time from the ACC/AHA was 120 minutes. However, administration and staff were committed to doing better and set the ambitious goal of reducing D2B times to 90 minutes. ThedaCare went to work and engaged key stakeholders, including cath lab and emergency department clinicians, administrators and emergency services personnel.  Armed with clipboards, the team began observing the processes for admitting, treating and discharging PCI procedures. The team found the cath labs were reaching a 90-minute metric only 58 percent of the time.

Process for Improvement

The cath labs began a series of rapid improvement events (RIE) that would help physicans, nurses and staff identify and eliminate the waste in their daily tasks. In an RIE, a consultant leads the team in an intensive forum where new ideas on how to eliminate waste are trialed and put in place if they work.

The first event in November 2005 focused on bringing the average times below 90 minutes.  The next event on May 2007 was to raise the bar and bring average times below 60 minutes.  The team developed innovative ways to speed up the process and remove waste. They created posters that hang in each of the emergency department (ED) rooms that outline each step in the process, which was a great visual cue.  As the emergency department  team treated the patient with chest pain or heart attack, they used the poster as a guide, calling out the next step in the process.  

We reduced our average door-to-balloon time from 74 minutes in 2006 to 66 minutes for 2007, resulting in nearly 30 minutes less when compared to the national benchmark.  

After the RIE, the cardiology interventionalists, ED physicians, ED nurses, cath lab nurses and techs implemented a new process for cardiac patients called Code STEMI. By utilizing Code STEMI, Theda Clark and Appleton Center emergency departments have been able to perform PCI procedures in as little as 17 minutes, and consistently perform the life-saving procedure well within the national benchmark of 90 minutes. In fact, they were able to achieve less than 90-minute D2B times 97.4 percent of the time in 2010.   
After the initial success of Code STEMI, ThedaCare went further and set a metric for in-house D2B STEMIs of 60 minutes. By engaging staff in another RIE, the cath labs were able to achieve 60 minutes 84.4 percent of the time in 2010 through process improvement.
Remote and Field Code STEMI Activation Drops D2B Times Further

Over the last two years, the ThedaCare cath labs have expanded their STEMI processes to seven other hospitals with Remote Code STEMI, as well as four field ambulance services.

When a patient arrives at a ThedaCare facility and is experiencing chest pain, the Code STEMI process begins – quickly and efficiently. ThedaCare also is working with area first responders, ThedaStar air transport and rural hospitals to ensure the 90-minute door-to-balloon time is achieved for its remote and field STEMI patients.   

The following is one case example from a patient who arrived at New London Family Medical Center (NLFMC) and was flown by

ThedaStar to Appleton Medical Center (AMC). It includes a breakdown of the event and the elasped time:
•  Patient arrives at NLFMC: 0 minutes
•  Patient receives electrocardiogram (ECG):
3 minutes
•  Physician reads ECG and diagnoses STEMI: 7 minutes
•  Code STEMI activated and ThedaStar helicopter departs Theda Clark: 14 minutes
•  Helicopter arrives at NLFMC: 26 minutes
•  Patient transferred to helicopter and departs: 38 minutes
•  Helicopter arrives at Appleton Medical Center:    46 minutes
•  Patient prepped in catheterization laboratory: 58 minutes
•  Patient receives angioplasty treatment of blocked artery: 77 minutes

Many of ThedaCare’s patients live outside of Appleton and Neenah, where we have catheterization labs. However, thanks to our efforts to improve Remote Code STEMI, rural patients now have access to this higher level of care through our partnerships with many outlying hospitals and first responders. We continue to track our performance and review every case to identify opportunities to shorten D2B times and bring them below 60 minutes.


Hypothermia May Help Preserve Heart Tissue in STEMI Patients

There is currently no proven therapy to reduce infarct volume, but a pilot study demonstrated use of mild hypothermia (below 35 C) in ST-elevated myocardial infarction (STEMI) patients prior to performing an angioplasty may help. Results showed a 38 percent preservation of heart tissue as compared to angioplasty alone. The study was presented at EuroPCR 2010.

Lund University in Sweden conducted the pilot study using Philips InnerCool endovascular cooling system, which uses both surface and endovascular cooling. The study, headed by Matthias Götberg, M.D., and Göran Olivecrona, M.D., is the culmination of more than 15 years of preclinical and clinical work in the area of myocardial preservation with the use of mild hypothermia.

Experimental studies have shown that induction of hypothermia before reperfusion of acute coronary occlusion reduces infarct size. Previous clinical studies, however, have not been able to show this effect, which is believed to be mainly because therapeutic temperature was not reached before reperfusion in the majority of the patients. This study aimed to evaluate the safety and feasibility of rapidly induced hypothermia by infusion of cold saline and endovascular cooling catheter before reperfusion in patients with acute myocardial infarction.

Twenty patients with acute myocardial infarction planned to undergo primary percutaneous coronary intervention (PCI) were enrolled in this prospective randomized study. After two to six days, myocardium at risk (MaR) and infarct size were assessed by cardiac magnetic resonance imaging (MRI) using T2-weighted imaging and late gadolinium enhancement imaging. A core body temperature of less than 35 C was achieved before reperfusion without significant delay in door-to-balloon time (an average of 43 minutes vs. about 40 minutes).

Despite similar duration of ischemia, infarct size normalized to MaR was reduced by 38 percent in the hypothermia group compared to the controls. This was supported by a significant decrease in both peak and cumulative release of troponin T in the hypothermia group.
The protocol demonstrates the ability to safely reach a core body temperature of less than 35 C before reperfusion without delaying primary PCI. It also showed that combination hypothermia as an adjunct therapy in STEMI resulted in a reduced infarct size.

Philips InnerCool Emergency Care Solutions is seeking to commence an 80-patient, multicenter, randomized trial in Europe to secure the CE mark indication for cooling of STEMI patients pre-PCI.

Related Content

Million Hearts Cardiovascular Disease Risk Reduction Model, CMS, reduce heart attacks and strokes, participants
News | Patient Engagement| July 22, 2016
July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states,
heart failure, after first heart attack, cancer risk, JACC study
News | Cardiac Diagnostics| July 21, 2016
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared...
Absorb, bioresorbable stent, BVS
Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth revolution of inte
Sponsored Content | Videos | Inventory Management| July 19, 2016
You have bigger priorities than managing inventory.
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable| July 19, 2016
Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with coronary artery...
Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons| July 18, 2016
Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon...

A 3-D OCT rendering of a stented vessel segment created on St. Jude Medical's Ilumien Optis OCT system. 

Feature | Angiography| July 15, 2016 | Dave Fornell
While angiographic X-ray fluoroscopy systems are the workhorse for transcatheter cardiovascular interventional proced
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
radial access, inserting stents, JACC Cardiovascular Interventions study
News | Radial Access| July 13, 2016
A new study in JACC: Cardiovascular Interventions supports access through the wrist, or radial access, as the default...
Toshiba, Infinix, 4DCT, CT-Angio

Toshiba’s Infinix 4DCT combines an Infinix Elite angiography system an Aquilion One Vision edition CT system. It allows clinicians to plan, treat and verify in a single clinical setting. The CT system is capable of capturing an entire organ in one rotation with 640 slices and 16 cm of anatomical coverage. 

Feature | Angiography| July 12, 2016 | Dave Fornell
Angiographic imaging system vendors have developed new technologies to address emerging cath lab trends, including th
Overlay Init